The investigation of allele and genotype frequencies of CYP3A5 (1*/3*) and P2Y12 (T744C) in Iran

Molecular Biology Reports

Volumn 38, Issue 8, 2011, Pages 4873-4877

  Azarpira, N ^a   Namazi, S ^b   Khalili, A ^b   Tabesh, M ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CYP3A5; Genotype; Iranian; P2Y12

Indexed keywords

ADULT; AFRICAN; AMERICAN; ARTICLE; CAUCASIAN; CHINESE; CONTROLLED STUDY; CYTOCHROME P450 3A5 GENE; DRUG METABOLISM; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENOTYPE; HUMAN; INDIAN; IRAN; IRANIAN; KOREAN; MALE; P2Y12 GENE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; VIET NAM;

ADULT; ALLELES; CYTOCHROME P-450 CYP3A; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PURINERGIC P2Y12;

EID: 84855225042     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0628-7     Document Type: Article

References (26)

1. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Rama-krishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB (2001) Identification of the platelet ADP receptor targeted by Antithrombotic drugs. Nature 409(6817):202-207 (Pubitemid 32144286)
2. Momary KM, Dorsch MP, Bates ER (2010) Genetic causes of clopidogrel nonresponsiveness: which ones really count? Phar-macotherapy 30:265-274
3. Fontana P, Gaussem P, Aiach M, Fiessinger JN, Emmerich J, Reny JL (2003) P2Y12 H2 haplotype is associated with peripheral arterial disease. A case-control study. Circulation 108:2971-2973 (Pubitemid 37553564)
4. Zee RY, Michaud SE, Diehl KA, Chasman DI, Emmerich J, Gaussem P, Aiach M, Ridker PM (2008) Purinergic receptor P2Y, G-protein coupled, 12 gene variants and risk of incident ischemic stroke, myocardial infarction, and venous thromboem-bolism. Atherosclerosis 197(2):694-699 (Pubitemid 351444788)
5. Smith SM, Judge HM, Peters G, Armstrong M, Fontana P, Gaussem P, Daly ME, Storey RF (2006) Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy. Platelets 17(4):250-258 (Pubitemid 43890796)
6. Floyd MD, Gervasini G, Masica AL, Mayo G, George AL Jr, Bhat K, Kim RB, Wilkinson GR (2003) Genotype phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European-and African-American men and women. Pharmacogenetics 13:595-606 (Pubitemid 37311146)
7. Choi JH, Lee YJ, Jang SB, Lee J-E, Kim KH, Park K (2007) Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects. Br J Clin Pharmacol 64:185-191 (Pubitemid 47063248)
8. Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS, Schuetz E (2001) Sequence diversity in CYP3A and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27(4):383-391 (Pubitemid 32268418)
9. Lee SJ, Usmani KA, Chanas B, Ghanayem B, Xi T, Hodgson E, Mohrenweiser HW, Goldstein JA (2003) Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups. Pharmacogenetics 13(8): 461-472 (Pubitemid 37034588)
10. Tsuchiya N, Satoh S, Tada H, Li Z, Ohyama C, Sato K, Suzuki T, Habuchi T, Kato T (2004) Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients. Transplantation 78:1182-1187 (Pubitemid 39426437)
11. Fontana P, Dupont A, Gandrille S, Bachelot-Loza C, Reny JL, Aiach M, Gaussem P (2003) Adenosine diphosphate-induced platelet aggregation is associated with p2y12 gene sequence variations in healthy subjects. Circulation 108(8):989-995 (Pubitemid 37048230)
12. Frere C, Cuisset T, Morange PE, Quilici J, Camoin-Jau L, Saut N, Faille D, Lambert M, Juhan-Vague I, Bonnet JL, Alessi MC (2008) Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome. Am J Cardiol 101(8):1088-1093
13. http://www.ncbi.nlm.nih.gov/projects/SNP/snp-ref.cgi?rs=776746
14. Adler G, Łoniewska B, Parczewski M, Kordek A, Ciechanowicz A (2009) Frequency of common CYP3A5 gene variants in healthy Polish newborn infants. Pharmacol Rep 61(5):947-951
15. Zhao Y, Song M, Guan D, Bi S, Meng J, Li Q, Wang W (2005) Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus. Transplant Proc 37(1):178-181 (Pubitemid 40459728)
16. Bajpai P, Tripathi AK, Agrawal D (2010) Genetic polymorphism of CYP3A5 in Indian chronic myeloid leukemia patients. Mol Cell Biochem 336(1-2):49-54
17. Park SY, Kang YS, Jeong MS, Yoon HK, Han KO (2008) Frequencies of CYP3A5 genotypes and haplotypes in a Korean population. J Clin Pharm Ther 33(1):61-65
18. Veiga MI, Asimus S, Ferreira PE, Martins JP, Cavaco I, Ribeiro V, Hai TN, Petzold MG, Björkman A, Ashton M, Gil JP (2009) Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam. Eur J Clin Pharmacol 65(4):355-363
19. Cavallari U, Trabetti E, Malerba G, Biscuola M, Girelli D, Olivieri O, Martinelli N, Angiolillo DJ, Corrocher R, Pignatti PF (2007) Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease. BMC Med Genet 8:59
20. Lee JM, Park S, Shin DJ, Choi D, Shim CY, Ko YG, Kim JS, Shin ES, Chang CW, Lee JE, Jang Y (2009) Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans. Am J Cardiol 104(1):46-51
21. Lev EI, Patel RT, Guthikonda S, Lopez D, Bray PF, Kleiman NS (2007) Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel. Thromb Res 119(3):355-360 (Pubitemid 44918095)
22. http://www.ncbi.nlm.nih.gov/projects/SNP/snp-ref.cgi?rs=2046 934
23. Beitelshees AL, McLeod HL (2006) Clopidogrel pharmacoge-netics: promising steps towards patient care? Arterioscler Thromb Vasc Biol 26(8):1681-1683 (Pubitemid 44305317)
24. Farjadian S, Ghaderi A (2007) HLA class II genetic diversity in Arabs and Jews of Iran. Iran J Immunol 4(2):85-93 (Pubitemid 46983398)
25. Farjadian S, Ghaderi A (2007) HLA class II similarities in Iranian Kurds and Azeris. Int J Immunogenet 34(6):457-463 (Pubitemid 350126019)
26. Michelson AD (2009) New P2Y12 antagonists. Curr Opin Hematol 16(5):371-377